MRKR – Marker Therapeutics Inc
Marker Therapeutics, Inc.MRKR
$1.53Name : Marker Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $17,311,644.00
EPSttm : -1.32
Marker Therapeutics, Inc.
$1.53
4.79%$0.07Float Short %
2.19
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.14
EPS Last/This Y
EPS This/Next Y
0.51
Price
1.52
Target Price
8.17
Analyst Recom
1
Performance Q
20.47
Relative Volume
0.5
Beta
1.42
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | MRKR | 1.41 | N/A | N/A | 0 |
| 2025-06-03 | MRKR | 1.52 | N/A | N/A | 0 |
| 2025-06-04 | MRKR | 1.51 | N/A | N/A | 0 |
| 2025-06-05 | MRKR | 1.505 | N/A | N/A | 0 |
| 2025-06-06 | MRKR | 1.77 | N/A | N/A | 0 |
| 2025-06-09 | MRKR | 1.7 | N/A | N/A | 0 |
| 2025-06-10 | MRKR | 1.68 | N/A | N/A | 0 |
| 2025-06-11 | MRKR | 1.855 | N/A | N/A | 0 |
| 2025-06-12 | MRKR | 1.68 | N/A | N/A | 0 |
| 2025-06-13 | MRKR | 1.66 | N/A | N/A | 0 |
| 2025-06-16 | MRKR | 1.5 | N/A | N/A | 0 |
| 2025-06-17 | MRKR | 1.51 | N/A | N/A | 0 |
| 2025-06-18 | MRKR | 1.48 | N/A | N/A | 0 |
| 2025-06-20 | MRKR | 1.49 | N/A | N/A | 0 |
| 2025-06-23 | MRKR | 1.44 | N/A | N/A | 0 |
| 2025-06-24 | MRKR | 1.43 | N/A | N/A | 0 |
| 2025-06-25 | MRKR | 1.49 | N/A | N/A | 0 |
| 2025-06-26 | MRKR | 1.48 | N/A | N/A | 0 |
| 2025-06-27 | MRKR | 1.47 | N/A | N/A | 0 |
| 2025-06-30 | MRKR | 1.53 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | MRKR | 1.42 | -8.0 | - | -1.19 |
| 2025-06-03 | MRKR | 1.52 | -8.0 | - | -1.19 |
| 2025-06-04 | MRKR | 1.51 | -8.0 | - | -1.19 |
| 2025-06-05 | MRKR | 1.52 | -8.0 | - | -1.19 |
| 2025-06-06 | MRKR | 1.77 | -8.0 | - | -1.19 |
| 2025-06-09 | MRKR | 1.72 | -8.0 | - | -1.19 |
| 2025-06-10 | MRKR | 1.68 | -8.0 | - | -1.19 |
| 2025-06-11 | MRKR | 1.86 | -8.0 | - | -1.19 |
| 2025-06-12 | MRKR | 1.69 | -8.0 | - | -1.19 |
| 2025-06-13 | MRKR | 1.63 | -8.0 | - | -1.19 |
| 2025-06-16 | MRKR | 1.51 | -8.0 | - | -1.19 |
| 2025-06-17 | MRKR | 1.50 | -8.0 | - | -1.19 |
| 2025-06-18 | MRKR | 1.47 | -8.0 | - | -1.19 |
| 2025-06-20 | MRKR | 1.45 | -8.0 | - | -1.19 |
| 2025-06-23 | MRKR | 1.44 | -8.0 | - | -1.19 |
| 2025-06-24 | MRKR | 1.44 | -8.0 | - | -1.19 |
| 2025-06-25 | MRKR | 1.49 | -8.0 | - | -1.19 |
| 2025-06-26 | MRKR | 1.47 | -8.0 | - | -1.19 |
| 2025-06-27 | MRKR | 1.47 | -8.0 | - | -1.19 |
| 2025-06-30 | MRKR | 1.52 | -8.0 | - | -1.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | MRKR | 19.82 | 10.37 | 1.61 |
| 2025-06-03 | MRKR | 19.82 | 10.37 | 1.61 |
| 2025-06-04 | MRKR | 19.82 | 10.37 | 1.61 |
| 2025-06-05 | MRKR | 19.81 | 10.37 | 1.61 |
| 2025-06-06 | MRKR | 19.81 | 10.37 | 1.61 |
| 2025-06-09 | MRKR | 19.81 | 11.26 | 1.61 |
| 2025-06-11 | MRKR | 19.82 | 11.26 | 1.50 |
| 2025-06-12 | MRKR | 19.82 | 11.26 | 1.50 |
| 2025-06-13 | MRKR | 19.81 | 11.26 | 1.50 |
| 2025-06-16 | MRKR | 19.82 | 10.73 | 1.50 |
| 2025-06-17 | MRKR | 19.82 | 10.73 | 1.50 |
| 2025-06-18 | MRKR | 19.81 | 10.73 | 1.50 |
| 2025-06-19 | MRKR | 19.82 | 10.73 | 1.50 |
| 2025-06-20 | MRKR | 19.82 | 10.73 | 1.50 |
| 2025-06-24 | MRKR | 0.33 | -13.58 | 1.50 |
| 2025-06-25 | MRKR | 0.33 | -13.58 | 1.50 |
| 2025-06-26 | MRKR | 0.33 | -13.58 | 2.19 |
| 2025-06-27 | MRKR | 0.00 | -13.58 | 2.19 |
| 2025-06-30 | MRKR | 0.00 | -13.58 | 2.19 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.4
Avg. EPS Est. Current Quarter
-0.27
Avg. EPS Est. Next Quarter
-0.26
Insider Transactions
Institutional Transactions
-13.58
Beta
1.42
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
21
Growth Score
31
Sentiment Score
40
Actual DrawDown %
96
Max Drawdown 5-Year %
-98
Target Price
8.17
P/E
Forward P/E
PEG
P/S
3.04
P/B
1.18
P/Free Cash Flow
EPS
-1.33
Average EPS Est. Cur. Y
-1.19
EPS Next Y. (Est.)
-0.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-224.45
Relative Volume
0.5
Return on Equity vs Sector %
-112.1
Return on Equity vs Industry %
-92.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading